Basic information
Biomarker: MMRd/MSI-H
Histology type: endometrial cancer
Cohort characteristics
Country: Korea
Region: Seoul
Followed up time :
Subgroup 1 name : MMRd/MSI-H
Subgroup 1 number: 164
Subgroup 2 name: None-MMRd/MSI-H
Subgroup 2 number: 307
| Total number | Group I | Group I number | Group II | Group II number | Group III | Group III number | Group IV | Group IV number |
|---|---|---|---|---|---|---|---|---|
| 1093 | endometrial/uterine cancers | 471 | ovarian, tubal, and peritoneal cancers | 422 | cervical cancer | 186 |
Sample information
Conclusion: The frequency of MMRd/MSI-H is moderate to high in gynecologic cancers in the Korean population. MMRd/MSI-H could be effective predictive biomarkers in gynecologic cancers of any type.
Sample type : tissue
Sample method: immunohistochemistry
Disease information
Related information
Molecular function from UniProt:
